StockDriftsStockDriftsTop 3 Column Group LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| SRZN | Surrozen, Inc. | 56.46% | 1.92M | $49.7M | +0.00%(+0) | $49.78(-51.86%) | 2026-06-30 | |
| ORIC | ORIC Pharmaceuticals Inc. | 43.53% | 3.54M | $38.3M | +0.00%(+0) | $29.43(-52.87%) | 2026-06-30 | |
| RVMD | Revolution Medicines Inc | 0.01% | 46 | $9K | +0.00%(+0) | $33.14(+547.72%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | -3.70% | -10.70% | -26.97% | -79.22% |
| Top 20 Holdings Unweighted | +33.43% | +137.56% | -6.19% | -27.33% |
Column Group LLC reports $88.10M in US-listed equity holdings across 3 positions in its most recent 13F filing. Its largest disclosed positions are SRZN (56.5%), ORIC (43.5%) and RVMD (0.0%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned -10.70% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Sign up free to track Column Group LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Column Group LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1833486). View Column Group LLC’s 13F filings on SEC